Repligen Corp at UBS Global Healthcare Conference Transcript
Great. Welcome, my name is Dan Brennan, to Day 2 of UBS Global Healthcare Conference. Really pleased that everyone is here. I cover life science, tools, diagnostics and pharma services. Pleased to be joining on stage with CEO of Repligen Corporation, Tony Hunt. And in the audience, we have Sondra Newman.
We're going to have a breakout after this at the Alvin-Carnegie room. Before we start, just I want to refer you to the UBS website, www.com or ubs -- excuse me, www.ubs.com where you can view the analyst disclaimers.
So with that, Tony, I don't know if you want to -- I've a series of questions and well, I'll try to seek audience participation certainly. We have more than enough to go through, but feel free to jump, and I'll look up periodically. Tony, I don't know if you want to may be make some opening comments and then we can dig in.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |